A randomized, double-blind comparison of coformulated elvitegravir/ cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: Analysis of week 96 results
- 浏览0
JAIDS
483-486页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



